𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients.

✍ Scribed by M. Miozzo; G. Sozzi; E. Tagliabue; P. Radice; C. Calderone; U. Pastorino; S. Pilotti; M.A. Pierotti; G. Della Porta

Book ID
119105177
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
60 KB
Volume
52
Category
Article
ISSN
0165-4608

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Quantitative determination of the epider
Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: Evidence for down-regulation in cervical cancer
✍ Rainer Kimmig; Doris Pfeiffer; Helge Landsmann; Hermann Hepp πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 190 KB πŸ‘ 3 views

Expression of epidermal growth factor receptor (EGFR) was quantified by 2-color flow cytometry in cervical cancer (n = 73) and normal cervical epithelium (n = 11). EGFR was determined using a murine monoclonal EGFR antibody, and number of bound antibodies was quantified adding calibration beads with

Epidermal growth factor receptor mutatio
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
✍ Jin-Yuan Shih; Chien-Hung Gow; Chong-Jen Yu; Chih-Hsin Yang; Yih-Leong Chang; Me πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 161 KB πŸ‘ 2 views

## Abstract Recently, mutations in the __epidermal growth factor receptor__ (__EGFR__) gene in nonsmall cell lung cancer (NSCLC) patients were reported to correlate with gefitinib response. Less than 30% of NSCLC patients are surgically resectable; however, molecular analysis has to rely on nonsurg